vimarsana.com

India Business News: MUMBAI: Ind-Swift Labs said it will sell its active pharmaceutical ingredient (API) and contract research & manufacturing services (CRAMS) business to.

Related Keywords

Mumbai ,Maharashtra ,India , ,India Resurgence Fund ,Piramal Enterprises ,Ind Swift Labs ,Bain Capital ,Business News ,Synthimed Labs ,Bse ,Tapi ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.